You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
It’s still all about earnings numbers for analysts, who mostly appeared surprised on the downside when companies failed to meet expectations.
In the last week of a messy earnings season, we have big retailer Woolworths and the major airlines stepping up to the plate. It may not be pretty for the latter.
Our fundies today are Australian Ethical Investment equities analyst, Mason Willoughby-Thomas, and portfolio manager, Andy Gracey, and they tell us why this IT services company is a favourite.
NAB and Suncorp are proving that you can resurrect yourself if you have good management that focuses on what you’re good at.
The big healthcare companies – CSL, Resmed, Primary and Ramsey – have had big gains over the last six months, but struggling Cochlear could be the one to keep an eye on over the next six months.
In another busy week in the broker world, activity was based on whether or not companies met earnings guidelines. Ansell and Sonic both got upgrades.
After Leighton announced reasonable results last week, they were hit hard by the market, but if you believe in management, here’s why you should buy it for income.
More progress at Coles has helped Wesfarmers post a very good profit in 2013 and allowed the company to share some of the gains through a higher dividend and a capital return of 50 cents per share.
At the one-third mark, the percentage of companies disappointing the market is high, at 35%, although there is some good news in outlook statements.
The Australian reporting season continues to drive broker activity, but analysts seem to be struggling with share prices that are already reflective of better than forecast financial performances.
